TeleTrader 7/20/2023 J&J's Q2 sales rise by 6.3% to $25.5 billion
TeleTrader 7/18/2023 J&J joins drug price suits against US gov't
TeleTrader 5/4/2023 J&J's Kenvue reportedly valued at $41B for IPO
TeleTrader 4/24/2023 J&J reportedly hopes to raise $3.5B in Kenvue roadshow
TeleTrader 4/18/2023 J&J revenue grows 5.6% to $24.75 billion in Q1
TeleTrader 4/4/2023 J&J to pay $8.9B to settle claims talc products caused cancer
TeleTrader 1/30/2023 Wall Street closes with losses as Fed, earnings loom
TeleTrader 1/30/2023 J&J to challenge bankruptcy ruling
TeleTrader 1/30/2023 J&J talc unit's bankruptcy petition in US dismissed
TeleTrader 1/24/2023 J&J's Q4 sales down 4.4% to $24B on lower COVID-19 vaccine sales
TeleTrader 1/13/2023 J&J reportedly cuts COVID vaccine production
TeleTrader 11/1/2022 Abiomed skyrockets 50% on J&J's takeover deal
TeleTrader 10/18/2022 J&J to reduce headcount despite robust sales
TeleTrader 10/18/2022 J&J's Q3 sales up 1.9% to $23.8 billion
TeleTrader 9/14/2022 J&J launches $5B share buyback program
TeleTrader 8/12/2022 J&J to stop selling talc-based baby powder in 2023
TeleTrader 7/19/2022 J&J posts Q2 EPS of $1.8, dropping 23.4% YoY
TeleTrader 5/6/2022 FDA limits J&J vaccine use due to blood clot risks
TeleTrader 4/19/2022 J&J's Q1 sales up 5% YoY to $23.4B
TeleTrader 3/29/2022 CDC confirms additional boosters for over-50s
TeleTrader 2/19/2022 Johnson: Putin must know he would pay high price for invasion
GlobeNewswire 2/16/2022 Top NoSQL Innovators Honored with ScyllaDB Awards
TeleTrader 2/8/2022 Report: J&J quietly paused COVID vaccine production
TeleTrader 1/25/2022 J&J Q4 EPS soars 172.3% to $1.77
TeleTrader 12/30/2021 J&J booster 85% effective against hospitalization in S. Africa